Aim The Aging process is a major risk factor for the development of degenerative diseases, including cognitive impairment. Many studies have shown that reduced cognitive function is associated with low testosterone levels. This study was aimed to know the association between serum testosterone level and cognitive functions in men who showed mild cognitive impairment. Results A total of 112 men were recruited during the study period. The median age was 64 years old. One-hundred and one subjects underwent cognitive function test and serum testosterone assay. The mean MMSE score was 26 + 3.2 points, whereas the mean testosterone level was 14.7 + 5.72 nmol/L.
The process of aging is a major risk factor for the development of illnesses after the age of 28 years in developed countries which cause mortality, such as cardiovascular, cancer, and neurodegenerative disease such as senile dementia and Alzheimer disease. 1 Severe cognitive impairment (such as Alzheimer's disease) is one of the predictive factors of mortality at older ages. 2 A transitional condition between normal aging process and Alzheimer's disease is mild cognitive impairment (MCI). The prevalence of MCI is estimated between 3 and 20% in adult population aged 75 years or more.
Recently, low serum testosterone concentrations was thought to play an important role in age-associated cognitive impairment. 4, 5, 6 In blood, testosterone is mainly bound to its carrier protein, i.e. the sex-hormone binding globulin (SHBG). However, its active form is the bioavailable testosterone or free testosterone. The total and free testosterone levels represent the concentration of bioactive hormones in a man. 7 In elderly men, reduced testosterone production and increased SHBG cause hypogonadism. The administration of testosterone replacement therapy is frequently considered to treat hypogonadism in men as an equivalent of hormone replacement therapy in postmenopausal women. However, there is concern about giving exogenous testosterone which may promote hyperplasia or even adenocarcinoma of the prostate. One study has found that there is no difference of prostate volume or prostate-specific antigen (PSA) between hypogonadal men receiving testosterone and normal control, 8 but another study found significant increase of PSA level in elderly men receiving testosterone treatment. 9 Several studies have tried to explain the association between serum testosterone level and cognitive ability in young adults, with varying results. 10, 11, 12 Furthermore, many studies have shown that low endogenous testosterone is associated with impaired cognitive ability which could be partly restored by administering exogenous testosterone. Therefore, measuring serum testosterone concentration should be considered in men with cognitive impairment. 13 This study was aimed to know the association between testosterone concentration and cognitive function in men who have already shown mild cognitive impairment.
METHOD

Study design and subjects
This was a cross-sectional study in men aged 50 years or above in Siloam Hospital, Lippo Karawaci, Tangerang. The study population were male patients in Neuroscience Clinic complaining of decreased cognitive function. The study subjects were patients who came between 2002 and 2004, recruited by purposive sampling method.
Assessment of cognitive function
The assessment of cognitive function was done by using the 30-point Mini-Mental State Examination (MMSE) questionnaire including orientation (time and place), memory, concentration, language, and praxis. Respondents were asked to spell the word "WORLD" backward (D-L-R-O-W) and counting down from 100 in blocks of 7. The scores from each question were summed to get the total MMSE score. The Higher the score, the better the cognitive ability.
Serum Testosterone Measurement
Blood sample (10 mL) was taken ready from every subject and was stored at -70 o C until it was ready for assay. Measurement was done in the Clinical Pathology Laboratory, Siloam Hospital. Total serum testosterone concentration was measured by using enzyme-linked fluorescent assay (ELFA) method with VIDAS®. The normal reference value in normal adult men was 8-35 nmol/L.
Data analysis
Characteristics of the study subjects were analyzed descrip tively to see the distribution pattern. Bivariate analysis was done to know the correlation between total MMSE score and testosterone levels (Pearson correlation). Data analysis was done using statistical software, SPSS version 13.0 for Windows PC (SPSS Inc, Chicago, Illinois).
RESULTS
A total of 112 study subjects were recruited between 2002 and 2004 based on the study criteria. The mean age of the patients was 64.8 + 7.89 years, ranging from 50 to 91 years. The median age was 64 years. About half of the study subjects were between 60 and 70 years old ( Table 1) . Distribution of the study subjects was tested with Kolomogorov-Smirnov test and showed a normal pattern (p=0.200) although there were several extreme values (Figure 1 ). One-hundred and one subjects underwent cognitive function test using MMSE questionnaires, measurement of serum testosterone and prostate tumor marker, i.e. the prostate specific antigen (PSA) concentrations.
The mean and distribution of each variable is given in Table 2 . Data normality using Kolmogorov-Smirnov test showed that the distribution of MMSE score was abnormal (p<0.0001), i.e. shifted to the right. There were 81 (81%) patients who scored 25 or more, 38 (37.6%) among them had 28-30 scores ( Figure 2 ). Serum testosterone concentrations showed normal distribution pattern (p = 0.200) with Kolmogorov Smirnov test (Figure 3 ). 
Figure 2. Distribution of MMSE Scores Figure 3. Distribution of serum testosterone concentration (nmol/L)
Correlative analysis between cognitive factor and other study variables showed a weak positive correlation between MMSE score and educational level (positive correlation) but a weak negative correlation between MMSE score and educational level. The higher the MMSE score, the higher the educational level but the age group is lower. No significant correlation was found between MMSE score and testosterone or PSA concentrations (Table 3) . Cognitive function assessed by MMSE showed that most patients had scored more than 24 points, but the average was less than the normal value (30 points). It means that most subjects have already suffered from mild cognitive impairments. Generally, the MMSE score is categorized into 4 groups, i.e. normal (28-30), mild (24-27), moderate (19) (20) (21) (22) (23) and severe (0-18).
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This classification was chosen because it represents the degree of cognitive dysfunction and is frequently used in epidemiological studies. According to this classification, most of the patients (63.3%) already had impaired cognitive function. There were only 38 patients who were categorized as normal.
In this study, no correlation was found between cognitive function (MMSE score) and testosterone level. This could be due to the fact that most subjects were still within normal serum testosterone concentrations range. One study had used the testosterone concentration below 11.3 nmol/L (325 ng/dL) or free testosterone index (testosterone/SHBG) less than 0.153 nmol/nmol as cutoff points for hypogonadism.
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A longitudinal study in 547 men aged 59-89 years showed that the free testosterone level was correlated to the better memory test, but not with the MMSE score which showed more complex association. 17 Another study in 310 men aged 50 years or more found that the free testosterone concentration was positively correlated with general cognitive score ability. Men with higher free testosterone concentration had higher cognitive scores (p < 0.001), but it is not the case with total testosterone concentration.
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A recent study involving 70-year old men or more also did not show a significant difference if total testosterone concentration between respondents with standardized MMSE (SMMSE) score < 25 points and > 20 points (14.8 versus 15.2 nmol/L; p=0.118). However, between those SMMSE groups, there was a significant difference of free testosterone level (262 versus 278 pmol/L; p=0.003) and luteinizing hormone concentration (4.7 versus 4.1 IU/L; p<0,001). These results suggested that it is the free testosterone concentration, that plays a role in cognitive function of elderly men. 19 This current study did not assess the free testosterone concentration. The reasons were because the procedure to measure free testosterone concentration is more difficult and also costs higher than total serum testosterone concentration. However, free testosterone measurement could be recommended in patients with mild cognitive impairment or androgen deficiency in aging males needing testosterone replacement therapy. For this purpose, an assay of PSA as a screening tool for prostate cancer is needed since prostate malignancy could be aggravated by administering exogenous testosterone. In this study, there was a weak correlation (r=0.273) but significant (p=0.004) between total testosterone and PSA concentrations (data was not presented).
CONCLUSION
In this current study, men aged 50 years and above with symptoms of cognitive impairment did show decreasing MMSE score. However, this study fails to show any association between the MMSE score and testosterone level which might be due to the fact that most of the study subjects were eugonadal. Further study is needed to confirm this finding by measuring the freetestosterone level, especially whenever testosterone replacement therapy is being considered.
